Kaleido Biosciences Inc (KLDO)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Kaleido Biosciences Max Drawdown (5Y): 100.0% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 100.0% |
March 31, 2024 | 100.0% |
February 29, 2024 | 100.0% |
January 31, 2024 | 100.0% |
December 31, 2023 | 100.0% |
November 30, 2023 | 100.00% |
October 31, 2023 | 100.00% |
September 30, 2023 | 100.00% |
August 31, 2023 | 100.00% |
July 31, 2023 | 100.00% |
June 30, 2023 | 100.00% |
May 31, 2023 | 100.00% |
April 30, 2023 | 100.00% |
March 31, 2023 | 100.00% |
February 28, 2023 | 100.00% |
January 31, 2023 | 100.00% |
December 31, 2022 | 100.00% |
November 30, 2022 | 100.00% |
October 31, 2022 | 100.00% |
September 30, 2022 | 100.00% |
August 31, 2022 | 100.00% |
July 31, 2022 | 100.00% |
June 30, 2022 | 99.73% |
May 31, 2022 | 99.72% |
April 30, 2022 | 99.72% |
Date | Value |
---|---|
March 31, 2022 | 92.82% |
February 28, 2022 | 91.88% |
January 31, 2022 | 90.39% |
December 31, 2021 | 86.80% |
November 30, 2021 | 80.17% |
October 31, 2021 | 80.00% |
September 30, 2021 | 80.00% |
August 31, 2021 | 80.00% |
July 31, 2021 | 80.00% |
June 30, 2021 | 80.00% |
May 31, 2021 | 80.00% |
April 30, 2021 | 80.00% |
March 31, 2021 | 80.00% |
February 28, 2021 | 80.00% |
January 31, 2021 | 80.00% |
December 31, 2020 | 80.00% |
November 30, 2020 | 80.00% |
October 31, 2020 | 80.00% |
September 30, 2020 | 80.00% |
August 31, 2020 | 80.00% |
July 31, 2020 | 80.00% |
June 30, 2020 | 80.00% |
May 31, 2020 | 80.00% |
April 30, 2020 | 80.00% |
March 31, 2020 | 80.00% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
16.41%
Minimum
May 2019
100.0%
Maximum
Dec 2023
85.72%
Average
80.08%
Median
Max Drawdown (5Y) Benchmarks
FluoroPharma Medical Inc | 100.00% |
RenovaCare Inc | 100.0% |
Xeno Transplants Corp | 100.00% |
Entia Biosciences Inc | 99.95% |
Regenerx Biopharmaceuticals Inc | 100.00% |